Skip to content

Effect of an AI-Supported Chatbot on Nursing Students' Clinical Decision-Making in Gynecological Oncology

The Effect of an Artificial Intelligence-Supported Educational Chatbot on Nursing Students' Knowledge of Gynecologic Cancers and Clinical Decision-Making Skills: A Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07806396
Enrollment
110
Registered
2026-09-08
Start date
2026-06-20
Completion date
2026-09-01
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chatbot-Based Training, Clinical Decision-making, Gynecologic Cancers, Nursing Education

Keywords

Artificial Intelligence, Chatbot, Nursing Students, Virtual Patient, Gynecologic Oncology, OSCE

Brief summary

This randomized controlled trial aims to determine the effect of an artificial intelligence (AI)-supported educational chatbot (OSCE Coach Platform) on nursing students' knowledge of gynecologic cancers and their self-reported clinical decision-making skills. Third-year undergraduate nursing students will be randomized into either an intervention group, utilizing the AI-supported chatbot, or a control group, receiving conventional education. Both groups will be assessed before and after the intervention.

Interventions

OTHERAI-Supported OSCE Coach Platform

A custom web-based educational platform combining AI-supported virtual patient interaction with standardized case scenarios, predefined clinical tasks, and immediate rubric-based feedback.

Sponsors

Sakarya University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Enrolled as a third-year undergraduate nursing student. * Successfully completed the Obstetrics and Gynecology Nursing (Women's Health and Diseases Nursing) course. * Volunteered to participate and provided digital informed consent.

Exclusion criteria

\- No additional

Design outcomes

Primary

MeasureTime frameDescription
Change in Clinical Decision Making in Nursing Scale-Turkish Version (CDMNS-Tr) ScoreBaseline (Day 1, before the assigned study procedures) and immediately after completion of the assigned study procedures on Day 1.The CDMNS-Tr is a 40-item scale assessing self-reported clinical decision-making. Items are rated on a 5-point Likert scale ranging from 1 (never) to 5 (always), with eighteen negatively worded items being reverse-scored. Total scores range from 40 to 200, with higher scores indicating a higher self-perception of clinical decision-making abilities.

Secondary

MeasureTime frameDescription
Change in Gynecological Oncology Knowledge Test ScoreBaseline (Day 1, before the assigned study procedures) and immediately after completion of the assigned study procedures on Day 1.A 15-item multiple-choice test developed to evaluate cognitive learning outcomes regarding gynecological oncology and nursing care. Each correct answer is awarded 1 point, while incorrect or blank answers receive 0 points. Total scores range from 0 to 15, with higher scores indicating a higher level of knowledge.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 11, 2026